MedPath

Samsung Medical Center

Samsung Medical Center logo
🇰🇷South Korea
Ownership
Subsidiary
Established
1994-01-01
Employees
501
Market Cap
-
Website
http://www.samsunghospital.com

Structured Education Based on New Glucose Management Devices in Patients With Type 1 Diabetes Mellitus

Not Applicable
Conditions
Type 1 Diabetes Mellitus
Interventions
Behavioral: Structured Education for new glucose management devices
First Posted Date
2019-01-07
Last Posted Date
2019-03-25
Lead Sponsor
Samsung Medical Center
Target Recruit Count
50
Registration Number
NCT03794934
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Multicenter Registry for Angiography-Derived Quantitative Flow Ratio

Completed
Conditions
Ischemic Heart Disease
Interventions
Diagnostic Test: QFR assessment
First Posted Date
2019-01-03
Last Posted Date
2024-04-17
Lead Sponsor
Samsung Medical Center
Target Recruit Count
524
Registration Number
NCT03791788
Locations
🇰🇷

Inje University Ilsan Paik Hospital, Goyang-si, Korea, Republic of

🇰🇷

Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of

🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

and more 2 locations

Cell Free DNA for the Diagnosis and Treatment in Early NSCLC

Recruiting
Conditions
Non-small Cell Lung Cancer
First Posted Date
2019-01-02
Last Posted Date
2021-05-11
Lead Sponsor
Samsung Medical Center
Target Recruit Count
700
Registration Number
NCT03791034
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Bare Metal Stents and Drug Eluting Stents in Patients Who Underwent Blood Transfusion

Completed
Conditions
Revascularization
Percutaneous Coronary Intervention
Erythrocyte Transfusion
First Posted Date
2018-12-27
Last Posted Date
2018-12-27
Lead Sponsor
Samsung Medical Center
Target Recruit Count
28322
Registration Number
NCT03788148
Locations
🇰🇷

Samsung Medical Center, Seoul, Gang nam-Gu, Ilwon-Dong, Korea, Republic of

The Compliance of DAPT and Statins on Clinical Outcomes in Percutaneous Coronary Intervention Patients

Completed
Conditions
Platelet Aggregation Inhibitors
Percutaneous Coronary Intervention
Hydroxymethylglutaryl-coa Reductase Inhibitors
Compliance, Medication
Adherence, Medication
Persistence, Medication
First Posted Date
2018-12-24
Last Posted Date
2018-12-24
Lead Sponsor
Samsung Medical Center
Target Recruit Count
47291
Registration Number
NCT03785509
Locations
🇰🇷

Samsung Medical Center, Seoul, Gang nam-Gu, Ilwon-Dong, Korea, Republic of

The Effects of Anesthetics on Persistent Pain Following Breast Cancer Surgery

Completed
Conditions
Chronic Post-Procedural Pain
Breast Cancer
Interventions
Other: acute postoperative pain
First Posted Date
2018-12-20
Last Posted Date
2020-01-31
Lead Sponsor
Samsung Medical Center
Target Recruit Count
89
Registration Number
NCT03782896
Locations
🇰🇷

Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of

This Study is a Phase II Study of AZD6738 in Combination With Durvalumab in Patients With Solid Tumor (Cohort A (N=30): GC Who Have Failed Secondary Chemotherapy Treatments Regimen; Cohort B (B=30): Melanoma Patients Who Have Failed to IO)

Phase 2
Conditions
Gastric Adenocarcinoma
Malignant Melanoma
Interventions
First Posted Date
2018-12-19
Last Posted Date
2022-06-15
Lead Sponsor
Samsung Medical Center
Target Recruit Count
61
Registration Number
NCT03780608
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

The Long-term Clinical Outcomes and Patterns of Transfusion in PCI Patients: Retrospective Cohort Study

Completed
Conditions
Erythrocyte Transfusion
Percutaneous Coronary Intervention
Revascularization
First Posted Date
2018-12-14
Last Posted Date
2019-03-28
Lead Sponsor
Samsung Medical Center
Target Recruit Count
48786
Registration Number
NCT03776266
Locations
🇰🇷

Samsung Medical Center, Seoul, Gang nam-Gu, Ilwon-Dong, Korea, Republic of

The Effect of a Ankle Assist Robot on Gait Function and Cardiopulmonary Metabolic Efficiency in Stroke Patients

Not Applicable
Completed
Conditions
Stroke
Gait, Hemiplegic
Interventions
Device: Ankle Assist Robot
First Posted Date
2018-12-06
Last Posted Date
2019-12-09
Lead Sponsor
Samsung Medical Center
Target Recruit Count
45
Registration Number
NCT03767205
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Registry of BrentuximabVedotinin Patients With R/R Anaplastic Large Cell Lymphoma or Classical HL

Completed
Conditions
Relapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin Lymphoma
First Posted Date
2018-12-06
Last Posted Date
2022-02-07
Lead Sponsor
Samsung Medical Center
Target Recruit Count
90
Registration Number
NCT03766516
Locations
🇰🇷

Samsung Medical Center, Seoul, Gangnam-Gu, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath